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Thesis Portfolio Abstract 
Background: This portfolio contains two systematic reviews and several meta-analyses in 
the clinical field of psychosis and trauma. The aim of the first review was to synthesise 
findings relating to the acceptability of post-traumatic stress disorder (PTSD) treatments in 
people with psychosis. The aim of the second review was to synthesise and meta-analyse 
the prevalence figures and risk factors for psychosis-related PTSD (PR-PTSD). 
Methods: The reviews were conducted using narrative and meta-analytic techniques. 
Search processes followed Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines. 
Results and Conclusion: Detailed statistics are presented for each review. The first review 
found that PTSD treatments are generally acceptable in people with psychosis. Non-
participation rates were low, feedback about the tolerability of treatments was generally 
good and dropout rates were comparable to other PTSD treatment studies. The second 
review largely agrees with earlier studies’ conclusion that the evidence base for PR-PTSD 
as it stands makes it difficult to draw conclusions about prevalence rates. Hopefully, as 
awareness is raised into the issue of PR-PTSD firmer assessment processes will emerge, 
leading to more robust meta-analytic findings and research syntheses in the future.   
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Abstract 
Research suggests that clinicians are reluctant to offer treatments for post-traumatic 
stress disorder (PTSD) to people with psychosis due to fears that they will not be able to 
tolerate them and they may be harmful through exacerbating symptoms or increasing levels 
of risk. PTSD treatments have been found to be effective in psychotic populations; 
however, given that they are somewhat controversial, this review aimed to assess their 
acceptability. Studies’ findings relating to treatment credibility and satisfaction, attendance 
and adverse events were synthesised. Meta-analyses were carried out on non-participation 
and dropout data. Non-participation rates were low and had minimal heterogeneity. 
Dropout rates were significantly higher in studies from the USA than from The 
Netherlands, but it is likely that this was confounded by use of a stabilisation phase. 
Studies that did not use a stabilisation phase had higher retention of participants, perhaps 
because they experienced gains more quickly due to attending active treatment, which may 
have made them more motivated to continue. Participants generally found the treatments to 
be acceptable and reported satisfaction. Adverse effects are discussed in relation to this 
population. Finally, further clinical implications and study limitations are discussed. 
 9 
 
 
 
Introduction 
Between 50% and 90% of people with psychosis have experienced at least one 
trauma in their lives (Read, van Os, Morrison & Ross, 2005). Accordingly, the prevalence 
of post-traumatic stress disorder (PTSD) in people with psychotic disorders is relatively 
high, ranging from 12% to 29% (Achim et al., 2011). This is a clinically important issue as 
comorbid PTSD in psychosis has been associated with more severe PTSD symptoms, 
poorer quality of life and increased use of mental health services (Fan et al., 2008). 
Mueser, Rosenberg, Goodman and Trumbetta (2002) argue that PTSD can exacerbate 
psychosis directly, via hyperarousal, reliving and avoidance, and indirectly through 
outcomes associated with PTSD, such as substance misuse, retraumatization and 
difficulties socially.   
There are many established treatments for PTSD, for example in a meta-analysis, 
Bisson and Andrew (2009) found trauma-focused cognitive behavioural therapies such as 
prolonged exposure and cognitive processing therapy to be effective. They also found eye 
movement desensitization and reprocessing therapy (EMDR) and stress management 
training to be effective. Despite this range of treatments, they are not routinely being 
offered in clinical practice for people with psychosis (Walters, Hogg & Gillmore, 2016). 
This may be because people with psychosis are often excluded in PTSD treatment 
research, thus limiting the evidence base for this population. Even research promoting 
broader inclusion of service users in PTSD research makes a special case for psychosis 
(Bradley, Greene, Russ, Dutra, & Westen, 2005). De Bont, van Minnen and de Jongh 
(2013) found no adverse effects when offering PTSD treatments to people with psychosis 
and argue that this should be encouraging for clinicians who believe these treatments to be 
harmful (Frueh, Cusack, Grubaugh, Sauvageot & Wells, 2006). 
It could be argued that given these concerns, understanding the acceptability of 
psychological interventions for post-traumatic stress disorder (PTSD) in people with 
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psychosis is as important as investigating their effectiveness. A systematic review by 
Swan, Keen, Reynolds and Onwumere (2017) briefly discusses dropout rates and adverse 
effects during PTSD treatments with this population; however, this is not the focus of their 
review, and these data are not meta-analysed. This review builds upon Swan et al.’s (2017) 
work in this area, by considering ‘acceptability’ of these treatments more comprehensively, 
as in Sekhon, Cartwright and Francis’ (2017) research. As such, the following questions 
will be answered in this review, when possible using meta-analyses alongside a narrative 
approach:  
 1) What is the estimated non-participation rate? 
 2) What are the reasons for non-participation? 
 3) What is the estimated level of attendance at intervention sessions? 
 4) What is the estimated dropout rate?  
5) What are the reasons and risk factors for dropout?  
6) What is the perceived acceptability of interventions?  
7) How satisfied are participants with the interventions?  
8) What adverse effects are caused by interventions? 
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Method 
This review followed the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines (Moher, Liberati, Tetzlaff, Altman & The PRISMA 
Group, 2009). The protocol for this review was published on PROSPERO: the 
international prospective register of systematic reviews (National Institute for Health 
Research & University of York, 2016).  
Study selection  
Studies were identified by systematic searches of the following databases: 
PsycInfo, Embase, Cinahl, Medline, the National Center for PTSD research’s Published 
International Literature on Traumatic Stress (PILOTS), Cochrane Library and OpenGrey. 
Filters were applied to publication date and language in line with the inclusion criteria. 
Specific journals were searched separately: Schizophrenia Research, Schizophrenia 
Bulletin, Psychological Medicine and the Journal of Traumatic Stress.   
The following search terms were entered: ptsd or ‘post traumatic stress’ or 
‘posttraumatic stress’ or ‘post-traumatic stress’ or trauma* AND psychosis or psychotic or 
schizo* or ‘severe mental’ or ‘serious mental’ AND Treatment* or intervention* or 
therap* or psychotherap* or counselling or program* or rct or trial or pilot or feasibility. 
The reference sections of relevant review articles, book chapters and research 
papers were searched by hand. Unpublished data were sought by making a request from 
key authors (for example, authors of studies meeting inclusion criteria) and through 
ordering full texts of relevant dissertations and theses. 
Inclusion criteria 
The inclusion criteria were as follows:  
• Peer reviewed journal articles, dissertations and theses produced between 1980 and 
2017 and available in English;  
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• Controlled or uncontrolled treatment studies exploring psychological interventions 
exclusively targeting PTSD and involving exposure to trauma related 
thoughts/memories/stimuli;  
• Participants meet PTSD threshold on a validated measure or interview for PTSD; 
• Participants meet criteria for psychosis on a validated measure or interview, or 
participants have an existing diagnosis of psychosis, or at least 50% of a mixed 
sample with severe mental illness have psychosis, or data were available for the 
subgroup of participants with psychosis.  
The term psychosis in this review refers to non-organic psychotic symptoms or 
psychotic disorders, including mood disorders with psychotic features. Disorders which 
may or may not include psychotic symptoms, such as bipolar disorder are excluded unless 
the presence of psychotic symptoms is mentioned. Articles reporting on the same dataset 
were included if they contained additional data related to the review questions. Case 
studies and qualitative studies were excluded. 
Screening 
Titles and abstracts were screened by the primary researcher and irrelevant studies 
were excluded. A collaborator cross-checked excluded titles. Full texts of relevant studies 
were retrieved and inclusion criteria applied independently by the primary researcher and 
collaborator. Further information was sought from authors when necessary. Disagreements 
were discussed and a second collaborator was consulted when necessary.  
Data extraction 
Data were extracted independently by the researcher and collaborator using a data 
extraction form and coding instructions (Appendix C). Disagreements were discussed and 
a second collaborator was consulted if required. Data were extracted in relation to 
methodology, population, setting, clinical characteristics, the psychological intervention 
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delivered, non-participation, attendance, dropout, perceived acceptability and satisfaction 
with the intervention, and adverse effects. This review focuses on these issues in relation to 
participants in the active treatment groups only. 
This review differentiates ‘non-participation’ from ‘dropout’. It defines ‘non-
participation’ as failing to attend any intervention sessions once assessed as eligible to 
receive the intervention, in line with Popay et al.’s (2006) definition. In controlled studies 
this refers only to those participants randomized to the treatment arm(s). As such, 
participants are considered non-participators if they withdrew after being offered treatment 
for their PTSD. Non-participation rates are calculated by dividing the number of non-
participators by the total number of participants eligible for treatment (in uncontrolled 
studies) or randomized to treatment (in controlled studies). The concept of non-
participation aims to capture participants actively opting out and therefore does not include 
those who were excluded by the researcher or were uncontactable. The number of 
participants who declined to take part in the study at any stage prior to eligibility 
assessments (in uncontrolled studies) or randomization (in controlled studies) will also be 
extracted and this will be referred to as ‘declining’ as opposed to ‘non-participating’ in 
order to differentiate between the two. 
 ‘Dropouts,’ for the purpose of this review refers to participants who attended at 
least one intervention session but failed to complete a sufficient ‘dose’ of sessions. It does 
not include those who completed a sufficient dose but were lost to follow up assessments.  
Non-participation reasons are any reasons given by participants for deciding not to 
take part in any intervention sessions once deemed eligible. These reasons are extracted 
separately from dropout reasons, which are reasons given by participants for dropping out 
of the study after completing at least one intervention session. 
Treatment acceptability and satisfaction refers broadly to any evaluative data or 
statements from participants about the treatment. The term ‘adverse effects’ refers broadly 
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to any negative outcome during treatment, including exacerbation of psychological 
symptoms, deterioration in functioning and any adverse events such as self-harm or drug 
use, including ‘serious adverse events’ such as deaths or incidents that require high-
intensity treatment (Klatte, Strauss, Flückinger & Rosendahland, 2018). All mentions of 
adverse effects and, crucially, whether they were treatment-induced will be extracted from 
the studies. As such, if studies found no adverse effects this will also be reported in this 
review, as this is considered just as relevant in understanding the acceptability of these 
treatments.  
Study quality 
Overall study quality was assessed using the Clinical Trials Assessment Measure 
on a scale of 0-100 (Wykes, Steel, Everitt, & Terrier, 2008). 
Data analysis 
Data were analysed using narrative and meta-analytic approaches. In order to 
calculate estimated non-participation and dropout rates, proportion meta-analyses were 
carried out using the statistical software Comprehensive Meta-Analysis Version 2 
(Borenstein, Hedges, Higgins, & Rothstein, 2005). A random effects model was used, as is 
preferable in social science research (Cooper, Hedges & Valentine, 2009). The inverse 
variance method was used in order to apply different weighting to studies based on sample 
size. Cochran’s Q was used as an indicator of heterogeneity and the I2 statistic to indicate 
how much of the variance observed between the results was due to random error. 
Subgroup analysis 
Subgroup analyses were carried out to determine whether intervention, population 
and methodological variables significantly affected non-participation and dropout rates. 
This was dependent on enough studies reporting the outcome of interest.  
Publication bias 
Publication bias was explored via funnel plots when there were sufficient studies.  
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Results 
Included studies 
Seventeen eligible studies were identified, based on 11 independent datasets (see 
Figure 1). Interrater agreement for study inclusion was 96.5% (Cohen’s Kappa 0.73, 
reflecting 'substantial agreement’). Steel et al.’s study (2017) was included despite their 
inclusion of participants with PTSD symptoms, because the majority had a diagnosis.  
Study characteristics are displayed in Table 1. In total, the studies included 333 
participants offered a PTSD intervention. Of these, 98.8% had a diagnosis of a psychotic 
disorder. The remaining participants took part in Sacks, Schwartz and Mueser’s study 
(2017) and had a diagnosis of bipolar disorder. 
PTSD treatments 
In this review, treatments referred to as ‘CBT’ use cognitive restructuring as the 
active treatment component. With the exception of Trappler and Newville (2007), the 
studies offering CBT used Mueser et al. (2007)’s protocols for group CBT or 
individualised CBT (Mueser, Rosenberg, Jankowski, Hamblen & Descamps, 2004), 
developed specifically for PTSD in people with serious mental illness (SMI). Trappler and 
Newville’s (2007) program includes elements of behavioural and schema modification but 
emphasises safety and emotional regulation. In this sense, it could be viewed as an 
enhanced and extended version of a traditional pre-exposure ‘stabilisation phase.’ Notably, 
three studies (de Bont et al., 2013; van den Berg & van der Gaag 2012; van den Berg et al., 
2015) purposefully omitted a ‘stabilisation phase.’ The remaining studies did not make 
reference to ‘stabilisation’ but initially offered relaxation skills and safety planning which 
typically serve this purpose. With the exception of three studies (de Bont et al., 2013; van 
den Berg & van der Gaag, 2012; van den Berg et al., 2015) treatments were adapted for 
people with psychosis or SMI, although in Grubaugh, Veronee, Ellis, Brown and Knapp 
(2017) the adaptation was simply offering additional sessions. 
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Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) flowchart. 
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                  Table 1 
                  Study characteristics 
Study no. First author Year Country Study design Treatment 
N in 
treatment 
arm(s) 
% Non-
participation 
Max. 
sessions 
offered 
No. sessions for 
'completion' 
Dropout 
(%) 
1 de Bont  2013 Netherlands Feasibility PE / EMDR 10 16.7 12 - 20.0 
2 Frueh 2009 USA Pilot Group / 1:1 PE 20 23.1 22 16 35.0 
3 Gottlieba 2011 USA RCT CBT  8 5.0 16 6 42.9 
4 Grubaughb 2017 USA Open trial PE 14 14.3 15 4 28.6 
5 Jansen 2017 Netherlands Case series ACT 3 - 12 - - 
6 Sacks 2017 USA Pilot Group CBT 14 - 21 11 28.6 
7 Steel 2017 UK RCT CBT 30 10.0 16 6 3.7 
8 Trappler 2007 USA Controlled  Group CBT 24 - 12 - - 
9 van den Berg 2012 Netherlands Pilot EMDR 27 10.0 6 - 18.5 
10 van den Bergc 2015 Netherlands RCT PE / EMDR 108 18.0 8 8 15.2 
11 Yanosd 2016 USA RCT CBT 75 - 16 6 36.0 
                       Note. a relates to the dataset Mueser et al., 2008, b relates to the dataset Grubaugh et al., 2016, c three secondary analysis studies were based on this   
                       dataset: van den Berg et al., 2016a, van den Berg et al., 2016b and van Minnen et al., 2016, d relates to the dataset Mueser et al., 2015. 
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Study quality 
Quality assessment scores are presented in Table 2. Interrater agreement was 87.0% 
(Cohen’s Kappa 0.64, reflecting ‘substantial agreement.’) As in Wykes et al. (2008), a cut-
off score of 65 on the CTAM has been used. Studies scoring 65 or greater are referred to as 
‘high quality’ and those with less than 65 ‘low quality.’ Areas of strength for this set of 
studies were treatment process and analysis. Treatment processes include use of protocols 
and therapist adherence to these. Items relating to analysis include use of ‘intention to 
treat’ analysis and appropriate handling of missing data. 
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                        Table 2 
                        Quality assessment scores using the Clinical Trials Assessment Measure (CTAM 
 
 
 
 
 
 
 
 
First author (date) Sampling (max. 10) 
Randomisation 
(max. 16) 
Assessment process 
(max. 32) 
Control group 
(max. 16) 
Analysis 
(max. 15) 
Treatment 
(max. 11) Total score 
Study 
quality 
van den Berg (2015) 7 16 26 16 15 11 91 High 
Steel (2017) 7 16 26 6 15 11 81 High 
Gottlieb (2011) 2 16 29 6 15 11 79 High 
Yanos (2016) 7 13 26 10 5 11 72 High 
de Bont (2013) 2 10 6 10 11 6 45 Low 
Grubaugh (2017) 7 0 6 0 15 11 39 Low 
Frueh (2009) 2 0 6 0 15 11 34       Low 
Sacks (2017) 2 0 6 0 15 6 29 Low 
van den Berg (2012) 2 0 6 0 15 6 29 Low 
Trappler (2007) 0 0 6 10 5 0 21 Low 
Jansen (2017) 2 0 6 0 5 6 19 Low 
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Non-participation rates 
Seven studies reported non-participation data. In three studies (van den Berg et al., 
2015; de Bont et al., 2013 & Frueh et al., 2009) it was unclear if participants had 
withdrawn pre or post-eligibility assessments; however, it was assumed they were eligible, 
as they were listed separately from those participants excluded due to ineligibility.  
A proportion meta-analysis using logits (see Figure 2) produced a pooled estimate 
of 12.1% for non-participation (95% CI 8.3%, 17.2%), with minimal heterogeneity (Q = 
4.77, df = 6, p = 0.574, I2 = 0.00). The two studies with the highest scores for quality had 
the lowest non-participation rates; however, meta-regressions were not possible due to the 
small number of studies. 
 
     Figure 2. Forest plot of non-participation meta-analysis.  
 
 
First author (date) Statistics for each study Event rate and 95% CI
Event Lower Upper 
rate limit limit p-Value
van den Berg (2015) 0.083 0.044 0.152 0.000
Steel (2017) 0.100 0.033 0.268 0.000
van den Berg (2012) 0.100 0.033 0.268 0.000
Gottlieb (2011) 0.125 0.017 0.537 0.069
Grubaugh (2017) 0.143 0.036 0.427 0.019
de Bont (2013) 0.167 0.042 0.477 0.038
Frueh (2009) 0.231 0.108 0.428 0.010
0.121 0.083 0.172 0.000
-1.00 -0.50 0.00 0.50 1.00
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Three studies reported the number of participants declining to be involved in the 
study pre-randomization. Van den Berg et al. (2015) and Steel et al. (2017) reported the 
number of participants who declined to take part in the study during the assessment phase, 
pre-randomization: 5.1% and 8.1% respectively of the total number of participants 
assessed. De Bont et al. (2013) reported the number of participants who declined when 
they were initially referred, pre-assessment, as 31.3%. No other studies reported the 
number of participants declining to be involved either pre-assessment (in uncontrolled 
studies) or pre-randomization (in controlled studies).   
Non-participation reasons 
Only two studies reported non-participation reasons. In de Bont et al (2013), two 
participants withdrew due to experiencing paranoia triggered by the video camera used to 
record sessions. In van den Berg and van der Gaag (2012), one participant withdrew due to 
ill health and the other withdrew due to increased stress caused by talking about his  
trauma. No further information was given. No studies reported data for differences 
between participators and non-participators. 
Attendance rates 
Attendance at treatment sessions cannot easily be summarised due to the 
inconsistencies in reporting. Three studies did not report on attendance. The remaining 
studies reported average attendance for either the intention to treat sample, treatment 
completers only, or treatment completers and non-completers combined. Alternatively, 
studies did not specify which participants had been included in the calculation.  
Dropout rates  
Figure 3 displays the forest plot for a proportion meta-analysis of dropout rates. 
The pooled estimate was 24.6%, (95% CI 16.9%, 34.4%) with significant heterogeneity (Q 
= 17.22, df = 8, p = <0.05, I2 = 53.54). Steel et al. (2017) was identified as an outlier. 
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When this study was removed, the overall estimate increased marginally to 26.4% (95% CI 
19.0%, 35.5%) but heterogeneity remained significant (Q = 12.50, df = 7, p = 0.085, I2 = 
43.99). 
 
         Figure 3. Forest plot for dropout meta-analysis. 
 
Moderator analyses results are displayed in Table 3. Further variables could not be 
analysed as they had multiple subgroups with a very small number of studies in each. 
Notably, country and stabilisation were found to be significantly associated with dropout 
and resulted in considerable reductions in heterogeneity. High quality studies had reduced 
heterogeneity as a group, but quality as a variable overall was not significant.  
First author (date) Event rate and 95% CI
Event Lower Upper 
rate limit limit
Steel (2017) 0.037 0.005 0.221
van den Berg (2015) 0.152 0.093 0.236
van den Berg (2012) 0.185 0.079 0.375
de Bont (2013) 0.200 0.050 0.541
Grubaugh (2017) 0.286 0.111 0.561
Sacks (2017) 0.286 0.111 0.561
Frueh (2009) 0.350 0.177 0.574
Yanos (2016) 0.360 0.260 0.474
Gottlieb (2011) 0.429 0.144 0.770
0.246 0.169 0.344
-1.00 -0.50 0.00 0.50 1.00
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Table 3 
Moderator Analysis Results  
 
Moderator k Dropout 
rate (%) 95% CI I
2 (%) Between groups test (Q) 
Overall 9 24.6 16.9, 34.4 53.5 - 
Study quality 
- - - - 1.78 
 High 4 30.6 19.5, 44.6 4.7 - 
     Low 5 20.0 12.2, 31.0 50.3 - 
Country 
    16.21*** 
 The Netherlands 3 16.2 10.9, 23.4 0.0 - 
 USA 5 34.7 27.0, 43.3 0.0 - 
     UK 1 3.70 - - - 
Intervention 
- - - - 0.80 
    CBT 4 29.4 17.4, 45.2 57.1 - 
    Non-CBT 5 21.8 13.6, 32.9 16.4 - 
Stabilisation phase 
- - - - 7.94** 
    Yes 6 32.8 25.5, 41.1 30.1 - 
     No 3 16.2 10.9, 23.4 0.0 - 
Note. **p=<0.01, ***p = <0.001 
Dropout reasons and risk factors 
Three studies reported dropout reasons. In de Bont et al (2013), one participant’s 
hallucinations forbade her from talking about her trauma. In van den Berg and van der 
Gaag (2012), reasons were: moving abroad, improvement in symptoms, no improvement in 
symptoms and not believing the treatment would be effective. One of the non-completers 
in Grubaugh et al. (2017) felt that the distress experienced when talking about the trauma 
had not improved. Notably, in Grubaugh et al. (2017) most of the non-completers did not 
attend any exposure sessions. 
Frueh et al. (2009), Grubaugh et al. (2017) and van den Berg et al. (2015) found no 
differences in demographics between non-completers and completers. Sacks, Schwartz and 
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Mueser (2017) found that non-completers were younger. Frueh et al. (2009) found that 
dropout was associated with being male and receiving an outpatient service as opposed to 
an intensive day-hospital program; however, these two variables (gender and service) were 
highly correlated.  
Clinical characteristics were not associated with dropout in Sacks et al. (2017). 
Frueh et al. (2009) found that non-completers had higher scores for anger than completers, 
but no differences in other clinical outcomes, treatment credibility rated pre-treatment, or 
treatment satisfaction scores. Yanos, Vayshenker, Pleskach and Mueser (2016) found that 
participants’ severity of impairment in insight was associated with dropout. Grubaugh et al. 
(2017) found that pre-treatment PTSD severity was associated with dropout, but index 
trauma was not. Referring to van den Berg et al.’s (2015) dataset, van Minnen et al. (2016) 
found that the dissociative subtype of PTSD was associated with dropout and van den Berg 
et al. (2016b) found no significant differences between dropouts and treatment completers 
in baseline variables (severity of PTSD symptoms, paranoia, auditory verbal 
hallucinations, negative symptoms, suicide risk, recent adversities such as self-harm or 
drug use, working memory or dose of antipsychotic medication). Finally, based on the 
same dataset, van den Berg et al. (2016a) found that exacerbation of PTSD, paranoid and 
depressive symptoms was not associated with dropout, although 2 of the 15 non-
completers experienced a significant exacerbation in PTSD symptoms.  
Treatment acceptability and satisfaction 
De Bont et al. (2013) reported that their treatment was acceptable as most 
participants could comply with it. Jansen and Morris (2017) asked open questions on how 
helpful the treatment was and how it could be improved. They reported ‘acceptability and 
satisfaction’ of the treatment but no details of participants’ responses. Sacks et al. (2017) 
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found participants to be ‘very satisfied’ with treatment, with an average score of 6.8 out of 
7 on a novel questionnaire.  
Frueh et al. (2009) used the Charleston Psychiatric Outpatient Satisfaction Scale 
(Pellegrin, Stuart, Maree, Frueh, & Ballenger, 2001) and reported that scores improved; 
however, only 5 of the 15 questions related to the treatment. They also used the treatment 
expectancy scales (Borkovec & Nau, 1972) and found that participants considered the 
treatment logical, were confident in its effectiveness in treating their current concerns and 
other fears, and would recommend it. Grubaugh et al. (2017) used the same measure with 
similar results, although participants were less confident of the treatment’s effectiveness, 
but more likely to recommend it. All items scored reasonably highly in both studies 
(between 6.83 and 8.47 out of 10). Grubaugh et al. (2017) also reported how difficult, 
confusing, and distressing participants found the treatment to be and how satisfying and 
worthwhile treatment had been. They reported low to moderate scores in the former 
category and moderate to high scores in the latter. 
In qualitative interviews, Grubaugh et al.’s (2017) participants reported that the 
treatment seemed credible and logical. Unfortunately, one participant’s experience was that 
although they found the treatment logical, they ‘failed’ because they ‘couldn’t handle it.’ 
The interviews also revealed that participants were initially very concerned about 
managing their distress during exposure, but for most people this reduced over the course 
of the treatment.  
Adverse effects 
Five studies of the 11 included in this review did not report whether they monitored 
for adverse effects. No serious adverse events caused by the treatments were observed in 
any of the studies. In the original paper for this study, van den Berg et al. (2015) state that 
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three serious adverse events occurred in the treatment conditions, but they were not 
deemed to be induced by the study and no other information was given.  
Frueh et al. (2009) reported hospitalisations during the treatment but did not 
consider these to be treatment-induced adverse events. They also reported no significant 
deterioration in psychological symptoms or functioning, due to the treatment or otherwise. 
Qualitative interviews in Grubaugh et al. (2017) indicated that neither PTSD or SMI 
symptoms were exacerbated by the treatment. Jansen and Morris (2017) asked participants 
open questions about whether the treatment had been unhelpful, harmful or distressing. 
They reported that there were no treatment-induced adverse effects; however, no 
information was given regarding participants’ responses. De Bont et al. (2013) also 
reported no adverse effects, which they defined as exacerbation of any psychological 
symptoms, deterioration in functioning, hospital admissions or other crisis interventions, 
change in medication, suicide attempts or self-harm. 
In terms of adverse effects caused by the treatments, van den Berg and van der 
Gaag (2012) found that their treatment exacerbated PTSD symptoms in some participants; 
however, in each case a single session on coping skills was sufficient to manage this. One 
participant sought support from his case manager due to increased arousal and this was 
managed by reminding him that EMDR causes temporary side effects. A relapse in drug 
use also occurred because a participant became able to leave the house alone due to 
treatment.  
Using reliable change indexes, van den Berg et al. (2016a) explored the rates of 
treatment-related symptom exacerbation during van den Berg et al. (2015)’s treatment. Pre 
to post-therapy exacerbation rates were 3.3% for PTSD interview scores, 3.3% for 
paranoid ideation, 9.9% for depressive symptoms and 0% for self-reported PTSD 
symptoms. They also assessed paranoid ideation, auditory verbal hallucinations, 
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dissociative feelings and suicidal ideation prior to treatment and after the first two sessions 
and found no exacerbation. By follow up, 11% of the participants in the treatment group 
began to hear voices, compared to 12% in the waiting list group. They report that overall, 
the treatment group experienced fewer adverse events (suicide attempts, aggressive 
incidents, alcohol and drug abuse and crisis interventions) than the control group and were 
less likely to experience revictimisation, but more likely to self-harm. The authors discuss 
the positive role the intervention may have played in the reduced number of adverse events 
in the treatment group as compared to the control group, but not the potential negative role 
the intervention could have played in causing the adverse events that did occur in the 
treatment group.  
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Discussion 
Non-participation  
Despite the ambiguity in reporting, the studies showed minimal heterogeneity 
suggesting a robust overall summary estimate of 12.1% for non-participation. 
Unfortunately, this cannot be compared to a non-psychotic PTSD population as there are 
no reviews on this to the author’s knowledge. 
As the non-participation decisions were post-randomization to treatment 
condition(s) (in controlled studies), non-participators were aware that they would receive a 
PTSD intervention if they continued to be involved in the study. As such, it could be 
interpreted that the participants withdrew because they did not find the treatment to be 
acceptable from the information they had been given. If this is generalisable to clinical 
practice, the perceived acceptability of these treatments (prior to receiving them) needs to 
be improved in this population, as otherwise approximately one in eight people with 
psychosis will refuse a potentially acceptable and effective treatment that they have been 
considered appropriate for. 
Pre-randomization non-participation rates are arguably less reflective of finding the 
treatment acceptable. Instead, it could be that the chance of being randomized to the 
control group may have lessened participants’ motivation to continue with the study. 
However, it would still be helpful for these data to be reported, with greater clarity as to 
the stage participants had reached in the recruitment process when they withdrew, to see 
when rates are highest and as a starting point for exploring the reasons.  
Dropout 
Dropout rates are comparable to other PTSD treatment studies (Hembree et al., 
2003, Bisson & Andrew, 2009), suggesting that when using dropout as a marker of 
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acceptability, these treatments are equally acceptable in psychotic as non-psychotic 
populations.  
Country is likely to be a confounder of the relationship between stabilisation and 
dropout, as Netherlands studies did not use stabilisation and USA studies did. Two studies 
(Frueh et al., 2009; Gottlieb, Mueser, Rosenberg, Xie, & Wolfe, 2011) found that most 
participants dropped out during skills training phase, which may suggest that engagement 
could be increased by omitting the stabilisation phase, so that participants are able to 
experience symptom improvement earlier on in the therapy. This is supported by a review 
by de Jongh et al., (2016), which raises doubt as to the necessity of a stabilisation phase 
given that the original research favouring its use was, in their opinion, methodologically 
flawed.  
The theory that dropout rates may be associated with severity of PTSD is supported 
by the findings of Grubaugh et al. (2017) of higher pre-treatment PTSD in non-completers. 
Also, there was a high dropout rate in Yanos et al.’s (2016) study, which was the only one 
to exclusively recruit participants with severe PTSD. Van den Berg et al. (2016a) found 
that exacerbation of PTSD, paranoid and depressive symptoms was not associated with 
dropout; however, this was based on data from only 37.5% of the dropout group and is 
therefore not representative of their experiences. 
Broadly, the idea that severity of symptoms may predict dropout may be supported 
by the significant associations of anger, impaired insight and dissociative insight with 
dropout. It will be important to explore these hypotheses further in psychotic populations, 
particularly given de Bont et al. (2013)’s finding that dropout was caused by the interaction 
of psychotic and trauma symptoms (hallucinations forbade discussion of the trauma). 
Research results are mixed as to the impact of severity of PTSD symptoms on dropout in 
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CBT for PTSD in non-psychotic populations. Whilst Garcia, Kelley, Rentz & Lee (2011)’s 
findings support this, Belleau et al.’s (2017) do not.  
Acceptability and satisfaction 
The findings regarding acceptability and satisfaction should be interpreted with 
caution as the data are very limited. Also, the range of assessments used, both qualitative 
and quantitative made reviewing the findings difficult. In the future, validated quality 
measures that are appropriate to this population should be used, such as the Verona Service 
Satisfaction Scale (Ruggeri et al., 2000). 
Questionnaire findings generally reflected satisfaction with the treatments; 
however, these results were often from treatment completers, therefore this outcome is 
somewhat expected. It will be important for future research to capture satisfaction scores 
and qualitative information from non-completers.  
Participants generally perceived the treatment to be credible and logical, although 
one participant withdrew from receiving EMDR as he did not. In Tarrier, Liverside and 
Gregg (2006)’s research, EMDR was deemed one of the least preferred treatments for 
PTSD.  
Adverse effects 
Research suggests that therapists are reluctant to offer PTSD treatments to people 
with psychosis due to fear of exacerbating their symptoms (van Minnen, Harned, Zoellner 
& Mills, 2012). This review suggests that for most participants, this does not occur, but 
when it does it does not usually prevent treatment completion or effectiveness.  
Van den Berg et al. (2016a) reported that a proportion of participants with no 
auditory hallucinations pre-treatment experienced them post-treatment; however, this was 
at a lower rate than in the ‘treatment as usual’ group and may have occurred regardless of 
the intervention given the fluctuating nature of psychotic illnesses.  
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Adverse effects are not always reported in psychological treatment studies and use 
inconsistent definitions adapted from drug trials (Klatte et al., 2018). The issue of whether 
adverse effects are caused by treatment is complex, particularly in psychotic populations 
given the higher level of risk behaviours. Many of the studies reporting on adverse effects 
relied on participants’ reports of whether they were precipitated by the treatment. This 
could bias responses, particularly if participants were motivated to continue with the 
treatment. Further research should explore whether adverse events such as hospitalisations, 
drug or alcohol abuse or revictimisation occur more frequently for people with psychosis 
after the onset of PTSD treatments, perhaps using staggered baseline periods before the 
introduction of treatments. This research would need to be large scale to ensure analysis 
was not underpowered, given it would involve naturalistic observation over time of 
relatively infrequent events. Other adverse effects, such as the exacerbation of clinical 
symptoms could also be recorded within this design.  
Clinical recommendations 
This review should increase clinicians’ confidence to offer evidence-based PTSD 
treatments to people with psychosis. The generalizability of the findings may be affected as 
not all participants in this review had a diagnosis of a psychotic disorder; however, the vast 
majority did, so the impact of this is likely to be negligible.  
Naturally, clinical judgement will determine the most appropriate timing and 
circumstances for these treatments, especially given the (albeit tentative) finding from this 
review that severity of symptoms may be associated with dropout. Engagement models 
which are common in specialist psychosis teams should be recreated in other settings when 
possible, to ensure that people with psychosis and severe PTSD are supported in accessing 
trauma therapy. It may also be important in treating PTSD in psychosis to determine the 
interaction between the two conditions and to create an integrated formulation as this may 
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increase the acceptability or effectiveness of the PTSD intervention. For example, a 
preliminary study using imaginal reprocessing to target both PTSD and psychotic 
symptoms gained positive feedback, had no dropout and there was no reliable worsening in 
any symptoms (Keen, Hunter & Peters, 2017).  
This review found that not including a stabilisation phase in PTSD treatments for 
psychosis may be associated with improved engagement; however, this should be 
interpreted with caution due to the very small number of studies. A randomised control 
trial is underway which is comparing stabilisation with no stabilisation in PTSD treatment 
(van Vliet, Huntjens, van Dijk, & de Jongh, 2018), so the results of this will further our 
understanding of this issue. 
Research recommendations 
Barriers to emotional engagement in the sessions could be explored, based on 
O’Driscoll, Mason, Brady, Smith and Steel’s (2016) finding that attendance at sessions 
does not always means people are engaging emotionally, which is required for treatment 
success. Session by session acceptability measures could be used to identify which 
elements or stages of treatment people struggle with. The Treatment Expectancy Scales 
could be asked in relation to different elements of the treatment and open questions could 
elicit more information as to how the treatment was perceived. Clearer and more consistent 
reporting of non-participation and dropout could be utilised, for example following the 
guidelines in Schottenbauer, Glass, Arnkoff, Tendick and Gray’s (2008) research. 
Reviews and empirical studies into the impact of PTSD treatments on psychotic 
symptoms should be carried out, so that the relative frequencies of exacerbation and 
improvement can be understood. Finally, it was beyond the scope of this review to include 
purely qualitative studies; however, further qualitative data would have enriched the 
findings about the acceptability of treatments. In future, a meta-synthesis of qualitative 
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studies and case studies would help to develop our understanding of the benefits and harms 
experienced by people with psychosis undertaking treatment for PTSD.  
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The previous chapter reviewed the acceptability of psychological interventions for 
post-traumatic stress disorder (PTSD) in people with comorbid psychotic disorders. These 
interventions are particularly important given the high comorbidity in these two disorders 
(Dallel, Cancel & Fakra, 2018) and worse prognosis if the two occur together (Fan et al., 
2008). The participants included in the review met diagnostic criteria for PTSD and a 
psychotic disorder; however, the order in which these developed, and any overlap or 
interaction between the two disorders were not reported. As mentioned briefly in the 
previous chapter, these issues could have implications for the acceptability and 
effectiveness of PTSD interventions in people with psychosis and therefore they warrant 
further understanding.  
Some of the potential pathways between PTSD and psychosis will be outlined here 
in order to highlight the complexity and uncertainty in this clinical field. Considering these 
mechanisms will expand on the diagnostic labels used in the previous chapter and provide 
a context for the content of the next chapter. Firstly, models proposing that trauma and 
PTSD contribute to psychosis will be reviewed. Secondly, some of the ways in which 
PTSD may develop after psychosis will be considered. Thirdly, the concept of psychosis-
related PTSD (PR-PTSD) will be introduced, followed by an exploration of the issues 
arising in defining and measuring this phenomenon. 
Schizophrenia spectrum disorders have traditionally been thought of as biologically 
based (Chua and Murray, 1996) but this research has been criticised for lacking 
methodological vigour (Bentall, 2013). This, in addition to the high prevalence of 
traumatic experiences observed in people with schizophrenia (Read & Ross, 2003) has led 
to a reconsideration of the importance of environmental influences, particularly childhood 
trauma (see Varese et al., 2012 for a review). Findings of a ‘dose response’ (Shevlin, 
Houston, Dorahy & Adamson, 2007) in which the risk of psychosis increases with the 
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amount of trauma experienced may also indicate that trauma contributes to the 
development of psychosis. The associations found between specific traumas and psychotic 
symptoms, such as between childhood sexual abuse and hallucinations, and between 
emotional abuse and delusions (Sitko, Bentall, Shevlin, O’Sullivan & Sellwood, 2014) are 
also thought to support this theory.   
One pathway to comorbid PTSD and psychosis is therefore that both disorders 
develop in response to trauma. The mechanisms for this remain unknown, but have gained 
increasing attention in the literature. For example, Read, Perry, Moskowitz and Connolly 
(2001) concluded through reviewing the data, that all the structural and chemical 
abnormalities found to be related to a genetic predisposition for schizophrenia had also 
been observed in traumatised children. This led to the traumagenic neurodevelopmental 
account of psychosis (Read et al., 2001) which states that if trauma is severe enough and 
occurs early enough in life, it can contribute to the development of psychosis through its 
impact on stress sensitivity, via the hypothalamic-pituitary-adrenal (HPA) axis and its 
subsequent impact on dopamine. PTSD has also been found to be associated with this 
dysfunction (Collip et al., 2013). Stress sensitivity is thought to result in either 
dissociation, or hypervigilance which are both maladaptive, but were initially adaptive 
coping strategies when the trauma could not be processed, or to protect against further 
abuse (Perry, Pollard, Blakley, Baker & Vigilante, 1995). These strategies may increase 
the risk for what we view as psychotic experiences. For example, Read et al., (2001) 
suggested that dissociation may be linked with negative symptoms, and hypervigilance 
with positive symptoms. These ideas extend the traditional stress-diathesis model (Walker 
& DiForio, 1997) that stress, including traumatic stress, simply serves to activate 
underlying neurobiological disturbances related to the stress sensitivity linked to 
schizophrenia.  
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Similarly, although from a cognitive perspective, Morrison, Frame & Larkin (2003) 
proposed that PTSD and psychosis are on a spectrum of responses to trauma and that both 
involve intrusions, but interpretation is the differentiating factor. It is the fact that people 
interpret intrusions as coming from an external source that leads us to classify the resulting 
symptoms as psychotic, because unlike other interpretations, these are considered 
culturally unacceptable (Morrison 2001). These attributions are thought to be influenced by 
beliefs about the self and others (Thomas, Farhall & Shawyer, 2015) which are themselves 
likely to be more negative and threat-based if the person has experienced trauma (Ehlers & 
Steil, 1995). Davidson and Strauss (1992) note that in trauma and in psychosis, cognitive 
appraisals of the self, the world and others have been shattered. It has been suggested that 
the variation in interpretation of trauma-related intrusions may be due to the extent to 
which the trauma-related memory was contextualised initially (Steel, Fowler & Holmes, 
2005). This draws upon Brewin (2001) and Ehlers and Clark’s (2002) cognitive models of 
PTSD and Hemsley’s (1994) information processing account of schizophrenia. Morrison et 
al. (2003) hypothesised that the more severe this contextualisation dysfunction, the more 
likely intrusions are and the more likely they are to be appraised as external. This could 
account for comorbid diagnoses of PTSD and psychosis following trauma; some intrusions 
could be viewed as trauma-related by the individual, and conceptualised by clinicians as 
flashbacks, whereas others could be viewed as coming from an external source and 
conceptualised as voice-hearing. It could also account for the finding that the more severe 
the PTSD, the more likely psychotic symptoms are to occur in conjunction with it, perhaps 
as a subtype of PTSD (Lindley, Carlson & Sheikh, 2000). This concept is limited in 
generalisability as much of the associated research focused exclusively on combat 
veterans, therefore a consensus on its existence has not yet been reached (Braakman, 
Kortmann & van den Brink, 2009). 
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The ideas summarised so far have focused on those with psychosis originating from 
trauma. Further research is required into the assumption that intrusions are qualitatively 
identical to anomalous experiences, and that risk of psychosis is on a continuum with a 
psychotic disorder, as many of the studies mentioned have used samples at risk of 
psychosis. Nonetheless, the potential route between trauma and psychosis is important as it 
offers a less stigmatising view of psychosis, and it may open up the potential for 
formulating and then treating the two sets of symptoms in an integrated way, potentially 
leading to faster recovery. It also helps to explain the overlap in symptoms in PTSD and 
psychosis, such as between negative psychotic symptoms and emotional numbing and 
avoidance in PTSD, and between hallucinations and trauma flashbacks. Further research is 
also needed on the differences between psychosis developing after a trauma history and in 
the absence of one. However, it is important to note that even if they did not experience 
trauma, it is likely that they experienced stressful events precipitating the psychosis which 
may have been perceived as traumatic despite not objectively being viewed as such 
(Fowler, 1997).  
An alternative potential pathway to a comorbid diagnosis of PTSD and psychosis is 
that psychosis predates the PTSD and they are discrete conditions. Sekar et al. (2016) 
propose that psychosis can have a strong genetic component or organic basis and Stevens, 
Spencer and Turkington (2017) argue that this type is distinct from a trauma-based 
psychotic presentation. This group are purportedly more emotionally avoidant and socially 
isolated which can lead to negative symptoms such as communication difficulties, poor 
cognitive functioning and poor motivation. Regardless of earlier trauma, those with 
existing psychosis may be more prone to experiencing trauma due to poorer coping 
strategies, income and overall quality of life (Norholm & Bech, 2007). For example, severe 
mental illness has been found to increase likelihood of violent victimization (Latalova, 
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Kamaradova & Prasko, 2014). Rates of substance use are also thought to be higher in 
people with psychotic disorders (Gregg, Barrowclough & Haddock, 2007) and Mueser, 
Rosenberg, Goodman & Trumbetta (2002) hypothesise that this may increase risk of 
trauma via exposure to unsafe situations, disinhibition or impaired judgement, although 
this is speculative and further research is required. Further to this, people with psychosis 
may be more likely to experience PTSD as a result of trauma due to their increased stress-
sensitivity (Walker & DiForio, 1997).  
The final pathway that will be considered is that the experiences of psychosis and 
its treatment can be sufficiently traumatic that they cause PTSD, referred to as PR-PTSD 
(psychosis-related PTSD). Critical to this concept is that psychosis can be defined as an 
index event for PTSD, yet this is a controversial issue. This will be discussed further in the 
next chapter, which reviews the prevalence and risk factors for PR-PTSD. Naturally the 
authors of the studies reviewed assume that psychosis can cause trauma as their starting 
point for their research.  
There are many important issues relating to the assessment of PR-PTSD. Psychotic 
and treatment experiences are likely to have persisted for a long time, so this makes it 
difficult for people to select the most distressing experience, as they would be asked to do 
in mainstream PTSD research (Green, 1996). The ongoing nature of the experiences may 
mean they would be better categorised as ‘complex trauma’ (than a single trauma) which 
may have a different symptom profile to PTSD (Cloitre et al., 2009). If the psychotic 
experiences are ongoing at the point of assessing PR-PTSD then it could reflect acute 
stress disorder (American Psychiatric Association, 2013) and not PTSD. Ongoing 
psychosis may also make it difficult to differentiate an intrusive memory of a hallucination 
or delusional belief from those occurring in present time. For example, a reminder of a 
delusion might trigger reliving the delusion, or it could be interpreted in a delusional way. 
47 
 
 
 
 
Intrusive memories reflecting PTSD must not be confused with more contextualised 
autobiographical memories which have been found in psychosis as well as other disorders 
(Brewin, Gregory, Lipton & Burgess, 2010). Finally, it may be difficult for people to 
determine whether their distress and dysfunction is caused by current symptoms of 
psychosis as opposed to past memories of it.  
The previous chapter involved participants with PTSD due to any traumatic event, 
but as these events were not always reported it is possible that a subset of the participants 
had PR-PTSD. Likewise, people could have had PR-PTSD alongside PTSD due to another 
traumatic event, developing either before or after the onset of the psychosis. Unlike the 
first chapter which focused on treating any PTSD comorbid to psychosis, the next chapter 
will only include studies in which the PTSD has been caused by the psychosis. As it is a 
new area of research, it will review the prevalence and risk factors of this proposed subtype 
of PTSD rather than its treatment as few treatment studies have been carried out.  
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Abstract 
Background: People with psychosis are more likely to have experienced trauma; however, 
there is a growing body of evidence indicating that psychosis itself can cause post-
traumatic stress disorder. The aim of this meta-analytic review was to determine the 
prevalence and risk factors of psychosis-related post-traumatic stress disorder (PR-PTSD). 
Method: Studies were identified in accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A random effects 
proportion meta-analysis was used to pool prevalence rates and the effect size Pearson’s r 
was extracted for meta-analysing for risk factors. 
Results: The review included 22 studies reporting on prevalence and/or risk factors for 
PR-PTSD for studies published between 1980 and 2017. The pooled prevalence estimate 
for PR-PTSD was 35.0% (95% CI 28.7%, 41.7%), with significant heterogeneity. 
Moderator analyses were conducted to explore this heterogeneity and whilst no factors 
were found to be significant, analyses of the following subgroups appeared to explain some 
of the heterogeneity: format of assessment, continent, non-affective psychosis and 
specificity of index trauma. The following risk factors had a moderate effects size: number 
of previous traumas, number of negative hospital experiences, anxiety, overall psychosis 
and depression, with the last two explored in more detail.  
Discussion: Findings are discussed in relation to the existing evidence base. 
Recommendations are made for clinical practice and further research. The strengths and 
limitations of this review are considered. 
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Introduction 
High rates of trauma and post-traumatic stress disorder (PTSD) have been found in 
people with psychotic disorders (Resnick, Bond & Mueser, 2003; Read & Ross, 2003); 
however, PTSD is often under-diagnosed in this population (Lommen & Restifo, 2009). 
This is particularly concerning given that this comorbidity is associated with a worse 
prognosis (Fan et al., 2008). It is therefore important that clinicians recognise symptoms of 
PTSD alongside psychosis so that appropriate treatments can be offered.  
There are many potential routes to comorbid PTSD and psychosis and interactions 
between the two. Consistently, trauma has been found to be an important contributor to the 
development of psychosis (Morgan & Gayer-Anderson, 2015) but conversely, people with 
psychosis may also be more susceptible to future trauma and PTSD (Stevens, Spencer & 
Turkington, 2017). A further pathway, that will be the focus of this review, is that the 
psychotic experience and its treatment could be sufficiently traumatic as to cause PTSD. 
This was first discussed by Shaner and Eth in 1989 and represents a growing area for both 
empirical studies and systematic reviews. Berry, Ford, Jellicoe-Jones, and Haddock (2013) 
first coined the term psychosis-related PTSD (PR-PTSD) which will be used throughout 
this review. This is defined as ‘PTSD induced as a result of experiencing psychotic 
symptoms and/or distressing experiences related to the treatment of psychosis.’ 
Whilst significant distress has been reported due to psychosis and its treatment 
(Bendall, Alvarez-Jimenez, Hulbert, McGorry & Jackson, 2012), psychosis does not 
technically meet the A criterion for an index trauma in the Diagnostic and Statistical 
Manual of Mental Disorders, 5th ed. (DSM-5; American Psychiatric Association, 2013) 
which requires direct or indirect exposure to actual or threatened death, serious injury or 
sexual violence. However, it is argued that PTSD develops based on appraisal of threat, 
regardless of objective risk (Kilpatrick, Saunders & Amick-McMullan, 1989) and levels of 
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perceived threat experienced by people with psychosis can be extremely high (Underwood, 
Kumari & Peters, 2016).  
Similarly to PTSD, PR-PTSD is often not recognised in clinical practice, which can 
lead to an increase in its severity (Hamner, Frueh, Ulmer & Arana, 1999). It is also thought 
to be associated with increased severity of psychotic symptoms, worse social functioning, 
drug and alcohol use and increased use and subsequent cost of mental health services 
(Mueser et al., 2002a). It is therefore important that awareness of PR-PTSD is raised. 
Many people suffering from an acute psychotic episode will continue to be 
supported by mental health services in the aftermath, thus providing opportunities for 
assessment and intervention of PR-PTSD. It is therefore important that clinicians are aware 
of the rates of PR-PTSD that could be expected and understand which factors may 
contribute to its development. A systematic review of PR-PTSD (Berry et al., 2013) from 
1980 to 2011 found prevalence rates of 11% to 67% for PR-PTSD. Given this large range, 
this review aims to meta-analyse prevalence rates in order to update Berry et al.’s (2013) 
review and explore reasons for the large range of prevalence estimates found.  In a recent 
systematic review, Fornells-Ambrojo, Gracie, Brewin and Hardy, (2016) found many 
differences in the assessment of PR-PTSD, but not did conduct meta-analyses and 
moderator analyses to explore the impact of these variables on prevalence. Rodrigues and 
Anderson (2017) reviewed PR-PTSD in first-episode psychosis only and found a pooled 
prevalence estimate of 30% (95% CI 21%, 40%). 
This review aims to synthesise and meta-analyse the prevalence figures and risk 
factors for PR-PTSD (without the restriction to first-episode psychosis). ‘Risk factor’ is 
used broadly to represent characteristics or experiences found to be associated with having 
or developing PR-PTSD.  
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Aims of the review 
1) What is the estimated prevalence of PR-PTSD?  
1a) What population and methodological variables moderate the estimated prevalence? 
2) What are the predictive strengths of risk factors of PR-PTSD? 
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Method 
The protocol for this review can be accessed on PROSPERO: the international 
prospective register of systematic reviews (National Institute for Health Research & 
University of York, 2016). This review followed the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Moher, Liberati, Tetzlaff, 
& Altman, 2009). 
Study selection 
This study sought to identify journal articles, dissertations or theses published in 
English from 1980 to October 2017. This was because in 1980 PTSD was first included in 
the DSM-III (American Psychiatric Association, 1980). The search terms used were:  
1) Psychosis OR psychotic OR postpsychotic OR post-psychotic OR ‘post psychotic’ 
OR psychosis-related OR ‘psychosis related’ OR schizo* OR ‘severe mental 
illness’ OR ‘serious mental illness’ OR ‘serious mental health’  
AND 
2) ‘Posttraumatic stress’ OR ‘post-traumatic stress’ OR ‘post traumatic stress’ OR 
PTSD OR trauma* 
Studies were identified through the following databases: PsycInfo, Embase, Cinahl, 
Medline, PubMed and the National Center for PTSD research’s Published International 
Literature on Traumatic Stress (PILOTS).  The following journals were searched 
individually: Schizophrenia Research, Schizophrenia Bulletin, Psychological Medicine and 
the Journal of Traumatic Stress. Additionally, the author checked the reference sections of 
relevant review articles, book chapters and research papers. In order to identify ‘grey 
literature’ relating to PR-PTSD, full texts of relevant dissertations and theses were 
requested and authors of key papers were contacted for unpublished data. 
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Inclusion criteria 
For review question 1, it was essential that studies included: (1) participants who 
have experienced at least one acute psychotic episode, (2) a validated self-report measure 
or interview for PTSD, rated based on the participants’ acute psychotic episode and/or its 
treatment, (3) prevalence of suspected PR-PTSD or sufficient data to calculate this. For 
review question 2, it was necessary that studies reported at least one factor associated with 
PR-PTSD, either explored through a correlation or comparison of the frequency or severity 
of the factor in PR-PTSD and no PR-PTSD groups. Qualitative studies and case studies 
were excluded. Studies were also excluded if the prevalence of PR-PTSD or effect size of a 
factor associated with PR-PTSD could not be established once the author had been 
contacted. If several papers referred to the same dataset, the paper judged as most relevant 
was selected, followed by the largest study if all papers were relevant. 
For the purposes of this review, an ‘acute psychotic episode’ was defined as a 
‘period of time in which severe symptoms of psychosis, including at least one positive 
symptom, required inpatient care or intensive outpatient care.’ 
Screening 
Initially, irrelevant studies were eliminated by the primary author based on their 
titles and abstracts. Full texts were retrieved for the remaining studies and reviewed against 
the inclusion criteria by the primary author. All studies were reviewed independently by a 
collaborator and disagreements were resolved by a second collaborator. Authors were 
consulted for further information if it was unclear if a study met the inclusion criteria.  
Data extraction 
The primary author extracted data for all included studies and a collaborator 
independently extracted the data for 50% of these, selected at random. A second 
collaborator was used as a mediator for any disagreements. Detailed data extraction was 
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carried out using a data extraction spreadsheet capturing the following areas: methodology, 
population, setting, clinical characteristics, study quality, reporting of prevalence of PR-
PTSD and analysis of factors associated with PR-PTSD (see Appendix C). 
The effect size Pearson’s r was chosen as the common metric for the risk factor 
meta-analyses due to ease of interpretation (Cooper, Hedges & Valentine, 2009). For non-
correlation studies, effect sizes were converted to r using Rosenthal’s guidance (1991). To 
do this, effect sizes were calculated from the descriptive data provided.  
When studies reported results at more than one timepoint the timepoint closest to 
the average time that measures were completed in the other studies was used. Outcomes 
from measures definitely completed within a month of the psychotic episode were 
excluded from analysis as PTSD cannot reliably be diagnosed at this time. When studies 
used a continuous measure and a categorical measure of the same risk factor, the effect size 
from the continuous measure was extracted due to its greater sensitivity. When studies 
reported prevalence or risk factors of both psychosis-related PTSD and hospital-related 
PTSD the two were merged using the guidance in Corey, Dunlap and Burke (1998). 
Subscales of measures were also merged to create a total score for the measure if 
necessary. Where beta coefficients were reported in the absence of any other data to 
calculate effect size, they were converted to r using Peterson and Brown’s (2005) 
technique. When necessary, Spearman’s r was used as a substitute for Pearson’s r (Hauke 
& Kossowski, 2011). When studies reported no association, but insufficient data were 
provided to calculate an effect size for the risk factor, r = 0 was used (Rosenthal, 1995). 
Study quality and risk of bias 
In order to determine study quality novel scoring criteria were created, based on the 
Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Studies Reporting Prevalence 
Data (Munn, Moola, Lisy, Riitano & Tufanaru, 2015) and the JBI Critical Appraisal 
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Checklist for Analytical Cross Sectional Studies (Moola et al., 2017). Duplications 
between the two checklists were removed and remaining items were adapted for the 
purpose of this meta-analysis to form a 10-point scoring system (higher scores reflecting 
higher quality studies with less risk of biased data). For the purpose of the analysis, studies 
with a score of 6 or greater were deemed ‘high’ quality and anything less than this ‘low 
quality.’   
In order to explore potential publication bias in the meta-analyses, funnel plots 
were explored when at least 10 studies were included (Higgins & Green, 2011) and the 
significance of this bias was tested using Egger’s test (Egger, Davey-Smith & Minder, 
1997). 
Prevalence of PR-PTSD 
A proportion meta-analysis with logit transformations was carried out to estimate 
the prevalence of PR-PTSD (Barendregt, Doi, Lee, Norman & Vos, 2013). For the risk 
factor meta-analyses, values of r were converted to Fisher’s z for the analysis and 
converted back to r for interpretation of the result. Meta-analyses were carried out on risk 
factors that were reported in three or more studies, as in Witt, van Dorn and Fazel, (2013).  
Random effects meta-analyses (Hedges & Olkin, 1985) were carried out using the 
statistical software Comprehensive Meta-Analysis, with studies weighted using the inverse 
variance method. Heterogeneity was assessed using Q and I2 statistics.  
Subgroup analyses 
The following subgroup analyses were planned, subject to study numbers: 
demographics, basic study characteristics such as location and design and methodological 
variables such as assessment measured used. 
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Results 
Included studies 
The search process produced 22 eligible studies for inclusion in the prevalence 
meta-analysis and/or in the risk factors meta-analyses (see Figure 1). Interrater agreement 
for inclusion/exclusion of studies was 95.2% (Cohen’s Kappa 0.63) reflecting ‘substantial 
agreement.’ 
See Table 1 for the characteristics of the included studies. Interrater agreement of 
extracted data items was 87.3% which reflects ‘fair agreement’ (Cohen’s Kappa 0.29). 
Two studies were theses (Pietruch & Jobson, 2012; Stubbins, 2004) and the rest were peer-
reviewed journal articles. Participants were civilian adolescents and adults, presenting to 
non-forensic inpatient services or community outpatient services. In the eight studies that 
assessed for previous trauma the average prevalence of previous trauma was 67.8%. 
Study quality 
Quality assessment and grading are displayed in Table 2. Four of the studies were 
deemed high quality. Interrater agreement for classification as high/low quality was 90.9%, 
reflecting ‘substantial agreement’ (Cohen’s Kappa 0.74). Most of the studies lacked power, 
had low response rates and had used convenience samples. 
Studies were inconsistent in their reporting of the timing of PTSD assessments 
post-psychosis (the range of means was 1.1 months to 4 years, with 14 not reporting this 
time). Studies were also unclear whether participants were assessed as inpatients or 
outpatients, whether the psychotic episodes had required hospitalisation and on whether a  
specific experience was the index trauma or the whole psychotic episode.
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Figure 1. Preferred Reporting Items for Systematic Reviews (PRISMA) diagram. 
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                         Assessment scores on the Clinical Treatments Assessment Measure (CTAM) 
 
  
67 
 
 
 
 
Lu et al., (2011), Abdelghaffar, Ouali, Jomli, Zgueb, and Nacef, (2016) and 
Mueser, Lu, Rosenberg and Wolfe, (2010) were the only studies to assess the trauma index 
event against criteria A1 and A2 in the Diagnostic and Statistical Manual of Mental 
Disorders 4th edition: DSM-IV (American Psychiatric Association, 2000). All other studies 
either excluded the need for these criteria to be met and thus did not assess for them or did 
not report anything regarding these criteria. 
Prevalence of PR-PTSD 
Twenty studies reported prevalence of PR-PTSD, yielding a sample of 892 
participants. A forest plot of the meta-analysis of prevalence is presented (Figure 2). No 
clear outliers were observed. Overall prevalence was estimated at 35.0% (95% CI 28.7%, 
41.7%, p = 0.00) and the Q test was significant (X2 =72.72, df = 19, p = 0.00, I2 = 73.87). 
This summary finding is reported as it may be of interest to the reader; however, it should 
not be considered a reliable estimate of PR-PTSD prevalence due to the ‘considerable’ 
heterogeneity (Deeks, Higgins & Altman, 2011) between studies.  
Sensitivity analysis 
Study quality (high/low) was not a significant moderator of prevalence. A meta-
regression of total quality score criteria was also non-significant.  
Priebe, Bröker and Gunkel, (1998) was the only study to assess PR-PTSD caused 
by treatment only (instead of treatment combined with psychotic symptoms). Removing 
this study had little impact, suggesting it was not unduly affecting the overall result.  
The decision was made to include all studies with a validated measure of PTSD in 
this review; however, three studies (Chisholm, Freeman, & Cooke, 2006; Jackson, Knott, 
Skeate, & Birchwood, 2004; Meyer, Taiminen, Vuori, Äijälä, & Helenius, 1999) used 
unconventional cut-off scores for their respective measures. When these studies were 
removed from the analysis, the impact on overall prevalence and heterogeneity was  
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Figure 2. Forest plot showing the results of the meta-analysis of PR-PTSD prevalence. 
 
 
 
 
Study Statistics for each study Event rate and 95% CI
Event Lower Upper 
rate limit limit
Meyer (1999) 0.109 0.046 0.236
Turner (2013) 0.140 0.068 0.266
Sin (2010) 0.197 0.115 0.315
Jackson (2009) 0.227 0.142 0.343
Kennedy (2002) 0.233 0.116 0.415
Centofanti (2005) 0.250 0.108 0.478
Berry (2015) 0.300 0.190 0.440
Lu (2011) 0.300 0.190 0.440
Brunet (2012) 0.308 0.184 0.467
Jackson (2004) 0.314 0.183 0.483
McGorry (1991) 0.345 0.197 0.531
Pietruch (2010) 0.382 0.237 0.553
Mueser (2010) 0.395 0.254 0.556
Abdelghaffar (2016)0.423 0.297 0.560
Bendall (2012) 0.472 0.317 0.633
Priebe (1998) 0.514 0.419 0.608
Stubbins (2014) 0.520 0.383 0.654
Shaw (2002) 0.524 0.375 0.668
Bernard (2006) 0.565 0.363 0.748
Chisholm (2006) 0.611 0.446 0.754
0.350 0.287 0.417
-1.00 -0.50 0.00 0.50 1.00
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negligible. This was perhaps because this group of studies included both the lowest and 
highest rates of prevalence. However, ‘leave one out’ analyses also had little impact on the 
overall outcome.  
It was decided that two studies (Brunet, Birchwood, Upthegrove, Michail & Ross, 
2012 & Kennedy et al., 2002) should be included despite slight ambiguity in the papers as 
to whether they used psychosis as the index event when assessing traumatic symptoms. 
Exclusion of these studies from the analysis caused a slight increase in overall prevalence 
and increased unexplained heterogeneity (I2) to 75.5%.  
Moderator analysis 
It was not possible to explore all the moderator variables defined a priori due to 
insufficient data reported. For example, studies did not use (or report on) subsamples of 
ages or gender. Summary statistics (e.g., percentage female/male or mean age) were not 
used as study-level characteristics for moderator analysis due to the loss of data involved in 
summarising in this way. It was also not possible to examine the time elapsed since the 
psychotic episode or ethnicity due to inconsistent reporting of these variables.  
Table 3 displays the moderator variables examined. None of these variables were 
found to be significant; however, this should be interpreted with caution as the analyses 
were underpowered. The impact of subgroupings on prevalence estimates and 
heterogeneity can be also be seen in Table 3. It should be noted that the level of specificity 
of index trauma was not always clearly reported, which affects the reliability of this 
analysis. 
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Table 3 
Moderators of prevalence 
Notably, heterogeneity reduced when studies using self-report measures to 
determine PR-PTSD were analysed separately and when studies excluding affective 
psychosis were analysed separately. 
 
Moderator k Prevalence (%) 95% CI I2 (%) Between groups test (Q) 
All studies 20 35.0 0.29, 0.42 73.9  
Location     0.004  
    Europe  11 35.1 26.7, 44.6 81.5  
    Non-Europe 9 35.8 30.8, 41.1 56.2  
Affective psychosis     0.548  
    Included 10 37.1 27.8, 47.5 84.4  
    Excluded 9 32.0 23.0, 42.6 57.6  
Psychotic episode     0.671  
    First 7 37.5 26.6, 49.8 74.8  
    Worst 8 31.5 22.2, 42.5 70.8  
    Most recent 5 36.9 23.8, 52.3 70.8  
Psychotic episode     0.584  
    Specific experience 6 32.0 21.8, 44.2 66.6  
    Whole episode 13 36.9 28.9, 45.7 76.2  
Type of measure     1.368  
    Interview 10 31.0 22.9, 40.6 80.0  
    Self-report 10 39.0 29.7, 49.3 66.6  
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Publication bias 
Egger’s test (Egger et al., 1997) for asymmetry of the funnel plot (see Figure 3) 
was significant (p = 0.02); however, the pooled prevalence estimate was not affected by the 
trim and fill method (Duval & Tweedie, 2000). 
  
 
Figure 3. Publication bias for PR-PTSD prevalence data.  
Risk factors of PR-PTSD 
Risk factors reported in three or more studies were analysed using separate meta-
analyses (see Table 4). These findings should be interpreted with caution if the meta-
analyses included a small number of studies, particularly if the studies in these analyses 
had small sample sizes.  
Eight of the studies assessed participants for previous trauma, but due to 
differences in the aspects of this that were assessed, the only risk factor meta-analysis 
performed was on number of previous traumas. The remaining findings related to previous 
trauma (that could not be meta-analysed) had mixed results ranging from non-significant 
effects for sexual abuse (Mueser et al., 2010) to a large effect size for the presence of 
childhood trauma (Bendall et al., 2012).  
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Table 4 
Meta-analyses of risk factors of PR-PTSD 
Note. *p = <0.01, **p = <0.001 
Number of previous traumas, number of negative hospital experiences, overall 
psychosis severity, anxiety and depression were found to have moderate effect sizes using 
Cohen’s (1988) criteria. The latter three were found to have high heterogeneity. Moderator 
  
 95% CI  Heterogeneity 
Risk factors k r Lower Upper   X2  I2 
Demographics        
    Level of education 3 -0.02 -0.16 0.12  0.21 0.00 
    Unemployed status 3 0.03 -0.34 0.40  15.31* 86.94 
    Gender (female) 5 0.04 -0.07 0.16  3.09 0.00 
    Age 4 -0.05 -0.17 0.08  1.56 0.00 
Clinical characteristics        
    Alcohol abuse severity (past 30 days) 3 0.00 -0.19 0.20  2.54 21.23 
    No. of previous admissions 5 0.02 -0.11 0.15  1.70 0.00 
    'Sealing over' recovery style 3 -0.06 -0.25 0.12  1.81 0.00 
    Negative symptoms severity 3 0.08 -0.17 0.32  4.66 57.10 
    Involuntary psychiatric admission 6 0.08 -0.05 0.20  4.88 0.00 
    Time since psychotic episode 3 -0.08 -0.41 0.26  4.81 58.38 
    Drug abuse severity (past 30 days) 3 0.09 -0.08 0.25  0.67 0.00 
    Duration of untreated psychosis (DUP) 4 -0.12 -0.27 0.04  3.28 8.49 
    Positive symptoms severity 3 0.17 -0.03 0.37  3.12 35.98 
    Psychosis severity (all symptoms) 10 0.22* 0.06 0.37  29.60** 69.56 
    No. of previous traumas 4 0.32* 0.11 0.49  4.97 39.57 
    No. of negative hospital experiences 3 0.32* 0.14 0.49  1.86 0.00 
    Anxiety severity 5 0.44* 0.13 0.64  20.98* 80.93 
    Depression severity 10 0.46** 0.28 0.61 
  
40.71** 77.89 
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analyses were carried out for depression and overall psychosis severity as there were 
sufficient studies (k = 10; Deeks et al., 2011).  
Depression 
Studies used self-report measures to assess depression; however, it was not possible 
to explore the impact of measure on effect size due to the wide range of measures used.  
A meta-regression based on study quality was non-significant (Q = 1.98, p = 0.159). I2 
reduced from 77.9% to 75.0%. 
Studies using correlations were compared to those in which r had been calculated 
based on Cohen’s d from a comparison of means. Figure 4 shows that this had a significant 
impact on the outcome. This was also significant (p = <0.05), although unexplained 
heterogeneity remained high (I2 = 62.6%).  
 
Figure 4. Moderator analysis of the associations between depression and PR-PTSD.  
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Psychosis severity 
Study quality was not found to moderate the strength of psychotic symptom 
severity as a risk factor. The measure used and the effect size calculation were also non-
significant as moderators. Heterogeneity reduced marginally when only analysing the 
subgroup of three studies in which the Brief Psychiatric Rating Scale (Overall & 
Gorham,1962) was used, but not when a subgroup of those using the PANSS (Positive and 
Negative Syndrome Scale for Schizophrenia; Kay, Fiszbein & Opler, 1987) was used, or 
any other measure. 
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Discussion 
Prevalence of PR-PTSD 
This review found that approximately a third of people experiencing psychosis 
have PR-PTSD. Rodrigues and Anderson (2017) found a similar result (30%; 95% CI 
21%, 40%) when recruiting participants with first-episode psychosis; however, this study 
included 11 of the 22 studies included in this review, therefore we would expect these 
estimates to be similar.  
Moderator analyses suggest that affective psychosis is associated with higher 
prevalence of PR-PTSD than non-affective psychosis. This is supported by findings that 
PTSD rates are higher in people with schizoaffective disorder than schizophrenia and 
higher still in depression and bipolar disorder (Mueser et al., 2004). It may be the case that 
an intense emotional reaction to trauma is negated by the negative symptoms of 
schizophrenia-spectrum conditions (Seow et al., 2016). 
Prevalence was higher in first-episode psychosis as opposed to most recent or worst 
episodes. This may be because of the negative impact the first-episode has on people’s 
views of themselves, the world and others (Dunkley, Bates & Findlay, 2015). Two further 
aspects of assessment may have resulted in an overestimation of the overall prevalence of 
PR-PTSD in this review. Firstly, the majority of studies did not rate PR-PTSD based on a 
specific experience. Secondly, most studies assessed for it while psychosis was ongoing, 
therefore potentially not allowing the recovery period of 1 month post-trauma before a 
diagnosis of PTSD can be made (American Psychiatric Association, 2013).  
There were insufficient studies to explore the effects of moderator variables when 
the impact of PR-PTSD measure was partialled out. This would have been useful as the 
tentative analyses conducted in this review indicate that a degree of heterogeneity can be 
explained by the specific measure used to assess PR-PTSD. For example, those studies that 
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assessed PR-PTSD using self-report measures may have overestimated its prevalence 
because these tools do not discriminate between symptoms caused by comorbid disorders 
as accurately as interviews such as the clinician-administered PTSD scale (CAPS; Blake et 
al., 1995) do.  
Risk factors of PR-PTSD 
Severity of depression and anxiety were found to be associated with severity of PR-
PTSD in this review; however, this finding does not imply causation and cannot explain 
the temporal order of these symptoms. Ginzburg, Ein-Dor & Solomon (2010) found PTSD 
to be a predictor of depression and not the other way around. The finding could also be due 
to psychosis causing high rates of both PR-PTSD and post-psychotic depression (Iqbal, 
Birchwood, Hemsley, Jackson & Morris, 2004) or they could both be due to a mediating 
factor. Notably, Sin et al., (2010) accounted for confounding variables and found no 
significant association between PR-PTSD and depression or anxiety.  
The finding that number of previous traumas was associated with PR-PTSD is 
interesting given the ‘dose effect’ (Shevlin, Houston, Dorahy & Adamson, 2007) of 
cumulative trauma on likelihood of psychosis. It may be that the risk of PR-PTSD after 
considerable previous trauma is mediated by the severity of the psychotic symptoms, as 
this was also found to have a moderate association with PR-PTSD.  
Strengths and limitations of this review 
This was an ambitious review in its scope and inclusion criteria. Search terms were 
sufficiently broad to avoid missing relevant papers, evidenced by the large number of 
studies retrieved initially. Protocols were followed and the levels of interrater reliability 
suggest the design is replicable. The findings must be viewed in the context of the 
methodological limitations of the study; however, they provide a useful snapshot of early 
hypotheses regarding PR-PTSD. 
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Recommendations for future clinical practice 
Clinicians should monitor for PR-PTSD, particularly in cases with comorbid 
depression and anxiety, or with a significant trauma history, including distressing 
hospitalisations. Rates of PR-PTSD could perhaps be reduced by improving experiences of 
treatment for psychosis. Interestingly, Meyer et al.’s (1999) study, which found a relatively 
low prevalence of PR-PTSD, included participants who were being treated using an 
actively non-coercive model. However, there are many other variables potentially 
impacting prevalence rates, so this hypothesis would need to be explored further.  
Recommendations for future research 
For many people, the experience of psychosis is highly distressing (Lu, Mueser, 
Rosenberg, Yanos & Mahmoud, 2017); however, its status as an index event for PTSD is 
unclear. In line with Brewin, Lanius, Novac, Schnyder & Galea’s (2009) 
recommendations, many studies in this review have emphasised core PTSD phenomena 
over trauma criteria and so this issue has not been discussed. This could be viewed as a 
passive approach, which is unlikely to lead to developments in defining PR-PTSD 
consistently. Fornells-Ambrojo et al., (2016) differentiate between PTSD caused by 
psychosis when criterion A in the DSM-5 (American Psychiatric Association, 2013) is met, 
referred to as ‘PR-PTSD,’ and PTSD caused by psychosis when this criterion is not met, 
referred to as ‘distorted reality PTSD.’ They describe the latter occurring when people are 
unable to appraise threat rationally due to their psychotic symptoms. These definitions may 
be a helpful way forward. 
The measure used to assess PR-PTSD explained some heterogeneity in prevalence. 
Ideally assessments would be consistent; perhaps the clinician-administered PTSD scale 
for schizophrenia (CAPS-S; Gearon, Thomas-Lohrman & Bellack, 2001) should be viewed 
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as the ‘gold standard’ due to its attempts to differentiate between PTSD symptoms and 
psychotic symptoms.  
When reporting assessments of PR-PTSD, the level of specificity of the index event 
should be explicitly stated, for example, whether participants’ symptoms were rated based 
on a particular hallucination or experience of restraint in hospital, or on their psychotic 
experience or admission in its entirety. For PTSD to be diagnosed as it would be in 
mainstream PTSD research, a specific event should be used as the index event.  
Research should continue to explore which elements of psychosis and treatment 
participants find most distressing in order to further our understanding of the mechanisms 
involved in the development of PR-PTSD. It is particularly important that prospective 
longitudinal studies are carried out into risk factors as opposed to correlational cross-
sectional studies. Qualitative research informed by a meta-synthesis would also be helpful 
in informing our understanding of potential risk factors for PR-PTSD, especially related to 
experiences of treatment. For example, Dunkley et al.’s (2015) qualitative study found that 
first-episode psychosis disrupted people’s views of the self, others and the world. They 
also argue that a PTSD diagnosis is too narrow to capture the extent of the distress caused 
by psychosis and its treatment. Finally, further randomised controlled trials into treatments 
for PR-PTSD should also be conducted in order that evidence-based interventions can be 
offered in clinical services.  
Conclusion 
Many complex potential interactions have been proposed between trauma, PTSD 
and psychosis and this remains an uncertain and developing clinical area. For example, 
trauma may cause psychosis and PTSD as discrete conditions (Okkels, Trabjerg, Arendt & 
Pedersen, 2017), PTSD and psychosis may be on a continuum of responses to trauma 
(Morrison, Frame & Larkin, 2003) or PTSD may develop after psychosis because of 
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increased risk to trauma due to the psychosis (Mueser, Rosenberg, Goodman & Trumbetta, 
2002). Finally, psychosis itself may cause PTSD, as has been discussed in this review. The 
latter pathway was the main focus for the authors in this review, which meant that only 
eight studies considered the role of previous trauma and only two studies assessed for 
PTSD concurrent with the PR-PTSD. These are important issues given the high rates of 
trauma in people with psychosis (Read & Ross, 2003), which were also reflected in this 
study; of those assessed, 67.8% on average had experienced a previous trauma. Given the 
well-established links between childhood trauma and psychosis (Varese et al., 2012) and to 
a lesser extent adult abuse and psychosis, (Pinheiro, Peixoto, Gomes, Campos & Mota, 
2015) it certainly seems important that future PR-PTSD research considers the prevalence 
and role of pre-existing trauma and PTSD and the potentially retraumatizing impact of 
psychosis.  
This is a relatively new area for research and it is unclear how PR-PTSD fits with 
the conceptualisation of PTSD in the DSM-5 (American Psychiatric Society, 2003). 
Perhaps inevitably given its novelty, there are many issues in its assessment, and 
inconsistencies in how it is defined. There is considerable heterogeneity in these areas in 
the studies reviewed, which precludes a robust conclusion regarding prevalence. Of 
particular note is the use of self-report measures in many of the studies, which is likely to 
lead to an overestimation in the rate of PR-PTSD as these tools do not distinguish between 
PTSD or other disorders as accurately as interviews do. This is particularly problematic 
given the high comorbidity in both PTSD and psychosis, (Strakowski, Keck & McElroy, 
1995; Bleich, Koslowsky, Dolev & Lerer, 1997) including overlap between psychotic and 
PTSD symptoms.  
Recommendations are that PR-PTSD should be assessed using a validated tool such 
as the CAPS-S (Gearon et al., 2004) on the basis of a specific traumatic event, at least a 
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month after it occurred and a differentiation should be made between objectively and 
subjectively traumatic psychotic or treatment experiences. 
Overall, the research reviewed raises helpful questions for developing our thinking 
around PR-PTSD and perhaps most importantly ensures that attention is drawn to the 
potentially traumatic nature of psychosis and its treatment. As discussed, PR-PTSD needs 
further investigation in order to determine the potential mechanisms involved and whether 
it has diagnostic validity. Regardless of the outcome, this will initiate discussion as to how 
we assess, treat and where possible prevent potential harm and distress that has been 
reported as a result of psychosis and its treatment (Lu et al., 2017).  
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Critical Evaluation & Additional Information 
This portfolio contains two systematic reviews and meta-analyses in the clinical 
field of psychosis and trauma, referred to in this chapter as ‘reviews’ for simplicity. Firstly, 
this chapter includes reflections on the overall process of conducting these reviews, with 
reference to the rationale behind important decisions. Secondly, their overall strengths and 
limitations as reviews are considered. Thirdly, the clinical and research implications of the 
findings of these reviews will be discussed.  
Reflections on review processes  
A proposal for the second review in this portfolio was approved by the University 
of East Anglia (Appendix D). The recommended changes were incorporated into the final 
design or considered carefully in research supervision if they were not. Dr Bonnie Teague 
confirmed that ethical approval was not required from the University of East Anglia 
Faculty of Medical and Health Sciences Ethics Committee for these reviews (Appendix E). 
Had the review identified restricted or confidential data, the issue of ethical approval 
would have been addressed accordingly with guidance from the university. This was not 
necessary, as the only unpublished data retrieved were from theses, which were openly 
available and had been approved by Ethics Committees at their respective universities.  
The reviews’ protocols were submitted to PROSPERO (National Institute for 
Health Research & University of York, 2016) which ensures transparency in the process, 
as the specifics in the original protocol must be adhered to regardless of how ideas for 
further research questions and analyses may develop as the review progresses. However, 
the earliest stage of these reviews naturally involved the iterative process of identifying 
broad aims and then conducting preliminary searches to gauge the evidence base, which 
further informs the aims. Given the relatively low number of studies identified initially, the 
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topics seemed appropriate choices for review; finding the balance between a novel area or 
angle and sufficient studies.  
When identifying aims for these reviews my placement was in an ‘early 
intervention in psychosis service’ and I heard that EMDR seemed an unwise choice for 
people with psychosis given its unusual methods, which it was thought could be interpreted 
as magical and enhance delusions. No reviews were found on the acceptability of PTSD 
treatments in people with psychosis; however, the research findings that therapists were 
reluctant to offer these treatments (Gairns, Alvarez-Jimenez, Hulbert, McCorry & Bendall, 
2015) seemed to suggest it was very important to understand this. The aims of my second 
review were based on the finding that no single review had encompassed the literature on 
the prevalence and risk factors for PR-PTSD in psychotic populations. Again, the 
complexity of differentiating between trauma symptoms and psychotic symptoms that was 
apparent on my placement led me to read about this issue, and subsequently to learn that 
psychosis itself could have been traumatising. A review of the measures used to determine 
PR-PTSD found high heterogeneity (Fornells-Ambrojo, Gracie, Brewin & Hardy, 2016); 
however, it seemed important that this area should be thoroughly reviewed and meta-
analysed so that readers could consider the findings and make their own judgements as to 
how useful the findings may be in furthering their understanding.  
Rationale for decisions 
The meta-analyses in this portfolio were either proportional using logits 
(Barendregt, Doi, Lee, Norman & Vos, 2013) or used correlations transformed to Fisher’s 
z for the analysis. Many methods are available for meta-analysis; however, these seemed 
appropriate due to their use in previous risk factor analyses (Trickey, Siddaway, Meiser-
Stedman, Serpell, & Field, 2012; Alisic et al., 2014) and as they were default settings on 
Comprehensive Meta-Analysis. Logits have been found to be less successful in stabilising 
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the variance (Barendregt et al., 2013); however, this particularly affects proportions close 
to zero or one so in practice the difference between the two methods was negligible. Using 
an effect size of zero for non-significant associations was conservative and may have 
underestimated the effect size, but this is thought to be preferable to excluding these data 
(Rosenthal, 1995). 
In the first review in this portfolio, the quality of studies was assessed using the 
Clinical Treatments Assessment Measure (CTAM; Appendix F). This was chosen due to 
its applicability to the studies in the review, based on preliminary searches during the 
design of the protocol. It was quickly apparent that pilots had been conducted alongside a 
few randomised controlled trials on this subject, which meant that standard quality tools 
such as the Cochrane Collaboration’s tool (Higgins & Green, 2011) which assesses against 
a gold standard of randomised controlled trials would have been inappropriate. The CTAM 
has been used in psychotic populations and whilst it includes items relating to 
randomisation and control groups these form part of a broader measure of study strengths. 
A cut-off score of 65 (used in Wykes, Steel, Everitt & Tarrier, 2008) was used for this 
review which was helpful for creating the distinction of ‘high quality’ and ‘low quality’ as 
a moderator variable. This approach has been argued to be preferable to using a continuous 
score for a quality measure, as it gives an overall flavour of study quality, whereas 
continuous scores can be misleading as they have often not received points due to a lack of 
reporting as opposed to a true lack of quality in the design. As long as this does not happen 
too often, it would not affect the assignment of ‘high’ or ‘low’ quality, and indeed if it did 
it could be argued to reflect genuine low quality as the more omissions made the less likely 
it may be that this is due to chance in what they decided to report.  
In the second review, a novel assessment tool was created, based on the Joanna 
Briggs Institute (JBI) Critical Appraisal Checklist for Studies Reporting Prevalence Data 
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(Munn, Moola, Lisy, Riitano & Tufanaru, 2015) and the JBI Critical Appraisal Checklist 
for Analytical Cross Sectional Studies (Moola et al., 2017). See Appendices G and H for 
copies of these tools. It seemed appropriate to combine these two tools due to the range of 
types of study in the review. 
Strengths & limitations of these reviews  
These reviews were clinically relevant and cover issues that clinicians will face in 
every day practice when providing psychological assessments and treatments. However, 
the reviews may have benefited from being more restricted in the scope of what they 
intended to cover, in order to allow expansion of a few key ideas. Failure to report findings 
would have introduced bias that should be avoided; however, this meant that many ideas 
had to be covered relatively briefly.  
Collaborators were two research assistants and interrater agreement was high, 
particularly regarding the inclusion and exclusion criteria. This supports the potential 
replicability of this review in the future, perhaps when enough new studies have been 
published to warrant this.  
Implications for research and clinical practice 
The first review found that PTSD treatments are generally acceptable in people 
with psychosis. Intuitively, the non-participation rates seem low with psychosis (less than 2 
in every 10 people); however, it was difficult to view this in the context of other treatments 
due to the specific and detailed way it was accessed in this review. The finding that 
dropout may be prevented though failing to use a stabilisation phase may be somewhat 
controversial, given the rationale for stabilisation seems very logical. When writing this 
review, I wondered whether or not any acceptability findings would be acted upon, given 
the current climate in health services and limited resources. Whilst offering service users 
choice about which PTSD treatment they preferred would be an ideal situation, I wondered 
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if this would be possible in practice given that clinicians in different localities may be 
trained in different specialist therapies. Finally, I wondered if changing the way these 
treatments are talked about may improve participants’ perceptions of them and perhaps 
lead to improved engagement. It would be difficult to assess this impact and would perhaps 
be experienced more as a ‘cultural shift’ in services. 
The second review largely agrees with Fornells-Ambrojo et al.’s (2016) conclusion 
that the evidence base for PR-PTSD as it stands makes it difficult to draw conclusions 
about prevalence. Hopefully, as awareness is raised into the issue of PR-PTSD firmer 
assessment processes will emerge, leading to more robust meta-analytic findings and 
research syntheses in the future.   
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Appendix A – Clinical Psychology Review Submission Guidelines  
Submission  
 
Our online submission system guides you stepwise through the process of entering 
your article details and uploading your files. The system converts your article files 
to a single PDF file used in the peer-review process. Editable files (e.g., Word, 
LaTeX) are required to typeset your article for final publication. All 
correspondence, including notification of the Editor's decision and requests for 
revision, is sent by e-mail. 
 
Peer review  
 
This journal operates a single blind review process. All contributions will be 
initially assessed by the editor for suitability for the journal. Papers deemed 
suitable are then typically sent to a minimum of two independent expert reviewers 
to assess the scientific quality of the paper. The Editor is responsible for the final 
decision regarding acceptance or rejection of articles. The Editor's decision is 
final. More information on types of peer review. 
Use of word processing software  
It is important that the file be saved in the native format of the word processor 
used. The text should be in single-column format. Keep the layout of the text as 
simple as possible. Most formatting codes will be removed and replaced on 
processing the article. In particular, do not use the word processor's options to 
justify text or to hyphenate words. However, do use bold face, italics, subscripts, 
superscripts etc. When preparing tables, if you are using a table grid, use only one 
grid for each individual table and not a grid for each row. If no grid is used, use 
tabs, not spaces, to align columns. The electronic text should be prepared in a way 
very similar to that of conventional manuscripts (see also the Guide to Publishing 
with Elsevier). Note that source files of figures, tables and text graphics will be 
required whether or not you embed your figures in the text. See also the section on 
Electronic artwork.  
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 
'grammar-check' functions of your word processor. 
Article structure  
 
Manuscripts should be prepared according to the guidelines set forth in the 
Publication Manual of the American Psychological Association (6th ed., 2009). Of 
note, section headings should not be numbered. 
Manuscripts should ordinarily not exceed 50 pages, including references and 
tabular material. Exceptions may be made with prior approval of the Editor in 
Chief. Manuscript length can often be managed through the judicious use of 
appendices. In general the References section should be limited to citations 
actually discussed in the text. References to articles solely included in meta-
analyses should be included in an appendix, which will appear in the on line 
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version of the paper but not in the print copy. Similarly, extensive Tables 
describing study characteristics, containing material published elsewhere, or 
presenting formulas and other technical material should also be included in an 
appendix. Authors can direct readers to the appendices in appropriate places in the 
text. 
It is authors' responsibility to ensure their reviews are comprehensive and as up to 
date as possible (at least through the prior calendar year) so the data are still 
current at the time of publication. Authors are referred to the PRISMA Guidelines 
(http://www.prisma-statement.org/statement.htm) for guidance in conducting 
reviews and preparing manuscripts. Adherence to the Guidelines is not required, 
but is recommended to enhance quality of submissions and impact of published 
papers on the field. 
Appendices  
If there is more than one appendix, they should be identified as A, B, etc. Formulae 
and equations in appendices should be given separate numbering: Eq. (A.1), Eq. 
(A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on. Similarly for tables and 
figures: Table A.1; Fig. A.1, etc. 
Essential title page information  
 
Title. Concise and informative. Titles are often used in information-retrieval 
systems. Avoid abbreviations and formulae where possible. Note: The title page 
should be the first page of the manuscript document indicating the 
author's names and affiliations and the corresponding author's 
complete contact information.  
Author names and affiliations. Where the family name may be ambiguous 
(e.g., a double name), please indicate this clearly. Present the authors' affiliation 
addresses (where the actual work was done) below the names. Indicate all 
affiliations with a lower-case superscript letter immediately after the author's 
name and in front of the appropriate address. Provide the full postal address of 
each affiliation, including the country name, and, if available, the e-mail address of 
each author within the cover letter. 
Corresponding author. Clearly indicate who is willing to handle 
correspondence at all stages of refereeing and publication, also post-
publication. Ensure that telephone and fax numbers (with country and 
area code) are provided in addition to the e-mail address and the 
complete postal address.  
Present/permanent address. If an author has moved since the work described 
in the article was done, or was visiting at the time, a "Present address"' (or 
"Permanent address") may be indicated as a footnote to that author's name. The 
address at which the author actually did the work must be retained as the main, 
affiliation address. Superscript Arabic numerals are used for such footnotes. 
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Abstract  
A concise and factual abstract is required (not exceeding 200 words). This should 
be typed on a separate page following the title page. The abstract should state 
briefly the purpose of the research, the principal results and major conclusions. An 
abstract is often presented separate from the article, so it must be able to stand 
alone. References should therefore be avoided, but if essential, they must be cited 
in full, without reference to the reference list. 
Graphical abstract  
Although a graphical abstract is optional, its use is encouraged as it draws more 
attention to the online article. The graphical abstract should summarize the 
contents of the article in a concise, pictorial form designed to capture the attention 
of a wide readership. Graphical abstracts should be submitted as a separate file in 
the online submission system. Image size: Please provide an image with a 
minimum of 531 × 1328 pixels (h × w) or proportionally more. The image should 
be readable at a size of 5 × 13 cm using a regular screen resolution of 96 dpi. 
Preferred file types: TIFF, EPS, PDF or MS Office files. You can view Example 
Graphical Abstracts on our information site. 
Authors can make use of Elsevier's Illustration Services to ensure the best 
presentation of their images and in accordance with all technical requirements. 
Highlights  
Highlights are mandatory for this journal. They consist of a short collection of 
bullet points that convey the core findings of the article and should be submitted in 
a separate editable file in the online submission system. Please use 'Highlights' in 
the file name and include 3 to 5 bullet points (maximum 85 characters, including 
spaces, per bullet point). You can view example Highlights on our information site. 
Keywords  
 
Immediately after the abstract, provide a maximum of 6 keywords, using American 
spelling and avoiding general and plural terms and multiple concepts (avoid, for 
example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly 
established in the field may be eligible. These keywords will be used for indexing 
purposes. 
Abbreviations  
Define abbreviations that are not standard in this field in a footnote to be placed 
on the first page of the article. Such abbreviations that are unavoidable in the 
abstract must be defined at their first mention there, as well as in the footnote. 
Ensure consistency of abbreviations throughout the article. 
Acknowledgements  
Collate acknowledgements in a separate section at the end of the article before the 
references and do not, therefore, include them on the title page, as a footnote to 
the title or otherwise. List here those individuals who provided help during the 
research (e.g., providing language help, writing assistance or proof reading the 
article, etc.). 
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Formatting of funding sources  
List funding sources in this standard way to facilitate compliance to funder's 
requirements: 
Funding: This work was supported by the National Institutes of Health [grant 
numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant 
number zzzz]; and the United States Institutes of Peace [grant number aaaa]. 
It is not necessary to include detailed descriptions on the program or type of grants 
and awards. When funding is from a block grant or other resources available to a 
university, college, or other research institution, submit the name of the institute 
or organization that provided the funding. 
If no funding has been provided for the research, please include the following 
sentence: 
This research did not receive any specific grant from funding agencies in the 
public, commercial, or not-for-profit sectors. 
Footnotes  
Footnotes should be used sparingly. Number them consecutively throughout the 
article. Many word processors can build footnotes into the text, and this feature 
may be used. Otherwise, please indicate the position of footnotes in the text and 
list the footnotes themselves separately at the end of the article. Do not include 
footnotes in the Reference list. 
Tables  
 
Please submit tables as editable text and not as images. Tables can be placed either 
next to the relevant text in the article, or on separate page(s) at the end. Number 
tables consecutively in accordance with their appearance in the text and place any 
table notes below the table body. Be sparing in the use of tables and ensure that the 
data presented in them do not duplicate results described elsewhere in the article. 
Please avoid using vertical rules and shading in table cells. 
References  
Citations in the text should follow the referencing style used by the American 
Psychological Association. You are referred to the Publication Manual of the 
American Psychological Association, Sixth Edition, ISBN 1-4338-0559-6, copies of 
which may be ordered from http://books.apa.org/books.cfm?id=4200067 or APA 
Order Dept., P.O.B. 2710, Hyattsville, MD 20784, USA or APA, 3 Henrietta Street, 
London, WC3E 8LU, UK. Details concerning this referencing style can also be 
found at http://humanities.byu.edu/linguistics/Henrichsen/APA/APA01.html 
Citation in text  
Please ensure that every reference cited in the text is also present in the reference 
list (and vice versa). Any references cited in the abstract must be given in full. 
Unpublished results and personal communications are not recommended in the 
reference list, but may be mentioned in the text. If these references are included in 
the reference list they should follow the standard reference style of the journal and 
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results' or 'Personal communication'. Citation of a reference as 'in press' implies 
that the item has been accepted for publication. 
Web references  
As a minimum, the full URL should be given and the date when the reference was 
last accessed. Any further information, if known (DOI, author names, dates, 
reference to a source publication, etc.), should also be given. Web references can 
be listed separately (e.g., after the reference list) under a different heading if 
desired, or can be included in the reference list. 
Data references  
This journal encourages you to cite underlying or relevant datasets in your 
manuscript by citing them in your text and including a data reference in your 
Reference List. Data references should include the following elements: author 
name(s), dataset title, data repository, version (where available), year, and global 
persistent identifier. Add [dataset] immediately before the reference so we can 
properly identify it as a data reference. The [dataset] identifier will not appear in 
your published article. 
References in a special issue  
Please ensure that the words 'this issue' are added to any references in the list (and 
any citations in the text) to other articles in the same Special Issue. 
Reference management software  
Most Elsevier journals have their reference template available in many of the most 
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support Citation Style Language styles, such as Mendeley and Zotero, as well as 
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Reference style  
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1. Submission 
2. Aims and Scope 
3. Manuscript Categories and Requirements 
4. Preparing the Submission 
5. Editorial Policies and Ethical Considerations 
6. Author Licensing 
7. Publication Process After Acceptance 
8. Post Publication 
9. Editorial Office Contact Details 
1. SUBMISSION 
Thank you for your interest in Early Intervention in Psychiatry. Authors should kindly note that 
submission implies that the content has not been published or submitted for publication elsewhere 
except as a brief abstract in the proceedings of a scientific meeting or symposium. 
Once the submission materials have been prepared in accordance with the Author Guidelines, 
manuscripts should be submitted online at http://mc.manuscriptcentral.com/eip 
For any queries regarding submission, please contact eip.eo@wiley.com. 
We look forward to your submission. 
By submitting a manuscript to or reviewing for this publication, your name, email address, and 
affiliation, and other contact details the publication might require, will be used for the regular operations 
of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for 
production and publication. The publication and the publisher recognize the importance of protecting 
the personal information collected from users in the operation of these services, and have practices in 
place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data 
collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-
protection-policy.html 
2. AIMS AND SCOPE 
Early Intervention in Psychiatry publishes original research articles and reviews dealing with the early 
recognition, diagnosis and treatment across the full range of mental and substance use disorders, as well 
as the underlying epidemiological, biological, psychological and social mechanisms that influence the 
onset and early course of these disorders. The journal provides comprehensive coverage of early 
intervention for the full range of psychiatric disorders and mental health problems, including 
schizophrenia and other psychoses, mood and anxiety disorders, substance use disorders, eating 
disorders and personality disorders. Papers in any of the following fields are considered: diagnostic 
issues, psychopathology, clinical epidemiology, biological mechanisms, treatments and other forms of 
intervention, clinical trials, health services and economic research and mental health policy. Special 
features are also published, including hypotheses, controversies and snapshots of innovative service 
models. 
In contrast with mainstream healthcare, early diagnosis and intervention has come late to the field of 
psychiatry. Early Intervention in Psychiatry creates a common forum for researchers and clinicians with 
an interest in the early phases of a wide range of disorders to share ideas, experience and data. This 
journal not only fills a gap, but also creates a new frontier in academic and clinical psychiatry. 
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Appendix C: Data extraction form and instructions 
Item descriptor Possible Codes Code/Value 
Study ID no Assign unique ID no   
Full Reference  Text. APA format   
Date of publication YYYY   
Country of origin Text   
Report type   1=peer reviewed 
journal article 
  
  2=dissertation/thesis 
  3=unpublished data 
  4=other (specify) 
Study design 1=cross-sectional   
2= prospective 
longitudinal 
3= other 
PR-PTSD data available in study 1=prevalence only    
  2=prevalence and 
risk factors 
  
Sample size Numeric   
Source of participants 1=community teams   
  2=psychiatric wards   
  3= 1 and 2   
  
4 = early 
intervention teams 
  
  
5=other/other 
combination 
  
Participants' diagnoses 
1=functional non-
affective psychotic 
disorders 
  
  
2=functional 
affective or non 
affective psychotic 
disorders 
  
  
3 = psychotic 
disorders not 
specified 
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PTSD 'caseness' according to: 
1=DSM III (or III-
R) 
  
  
2 = DSM IV/IV TR   
  
3 = DSM V   
  
 
  
  
4= ICD 10   
Mean age of sample Numeric   
Age range of sample Numeric   
Sample included adults only/Sample included 
adolescents and adults 
1=adults only 
≥18yrs 
  
2=adolescents/adults 
≥14yrs 
Percentage Male Numeric   
Percentage Female Numeric   
Sample hospitalised due to acute psychotic 
episode/mixed sample of hospitalised and non 
hospitalised 
1= hospitalised   
2= mixed sample 
Time of PTSD assessment 1= ≤1 month 
following APE 
  
2 = >1 to ≤6 months 
following APE 
  3 = ≥6 months 
following APE 
  
PTSD interview used 1 = name   
  2= name   
  3 = other validated 
interview 
  
  
4= none used   
PTSD self report measure used 1 = name   
  2= name 
  3 = other validated 
questionnaire 
  
  4= none used   
Prevalence of caseness PTSD due psychotic 
symptoms  
Numeric   
Prevalence of caseness PTSD due to treatment of 
psychosis including hospitalisation 
Numeric   
Prevalence of caseness PTSD due to combined 
report of either psychotic symptoms or treatment 
Numeric   
112 
 
 
 
Risk factor (1) measure type 1= validated self 
report 
  
  2= validated 
interview 
  
  3-other   
Risk factor (1) measure name 1= name   
  2= name 
  3= Other validated 
measure 
Effect size for risk factor 1 (r) Numeric   
Effect size calculation for risk factor 1 (if 
applicable) 
Text/numeric 
specifying data 
extracted for 
calculation 
  
Degrees of freedom Numeric   
Risk factor (2) measure type 1= validated self 
report 
  
  2= validated 
interview 
  
  3-other   
Risk factor (2) measure name 1= name   
  2= name 
  3= Other validated 
measure 
Effect size for risk factor 2 (r) Numeric   
Effect size calculation for risk factor 2 (if 
applicable) 
Text/numeric 
specifying data 
extracted for 
calculation 
  
Degrees of freedom Numeric   
Risk factor (3) measure type 1= validated self 
report 
  
  2= validated 
interview 
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  3-other   
Risk factor (3) measure name 1= name   
  2= name   
  3= Other validated 
measure 
  
Effect size for risk factor 3 (r) Numeric   
Effect size calculation for risk factor 3 (if 
applicable) 
Text/numeric 
specifying data 
extracted for 
calculation 
  
  
Degrees of freedom Numeric   
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115 
 
 
 
 
 
 
 
 
116 
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Appendix F: Clinical Trials Assessment Measure (CTAM) 
The Clinical Trials Assessment Measure (CTAM) (Wykes et al., 2008) 
Clinical Trials Assessment Measure (CTAM) 
Sample—two questions: maximum score = 10 
Q1: is the sample a convenience sample (score 2) or a geographic cohort (score 5), highly 
selective sample, e.g., volunteers (score 0) 
Convenience sample—e.g., clinic attenders, referred patients or Geographic cohort—all 
patients eligible in a particular area 
Q2: is the sample size greater than 27 participants in each treatment group (score 5) or 
based on described and adequate power calculations (score 5) 
Allocation—three questions: maximum score = 16 
Q3: is there true random allocation or minimisation allocation to treatment groups (if yes 
score 10) 
Q4: is the process of randomisation described (score 3) 
Q5: is the process of randomisation carried out independently from the trial research team 
(score 3) 
Assessment (for the main outcome)—five questions: maximum score = 32 
Q6: are the assessments carried out by independent assessors and not therapists (score 10) 
Q7: are standardised assessments used to measure symptoms in a standard way (score 6), 
idiosyncratic assessments of symptoms (score 3) 
Q8: are assessments carried out blind (masked) to treatment group allocation (score 10) 
Q9: are the methods of rater blinding adequately described (score 3) 
Q10: is rater blinding verified (score 3) 
Control groups—one question: maximum score = 16 
Q11: TAU is a control group (score 6) and/or a control group that controls for non-specific 
effects or other established or credible treatment (score 10) 
Analysis—two questions: maximum score = 15 
Q12: the analysis is appropriate to the design and the type of outcome measure (score 5) 
Q13: the analysis includes all those participants beginning treatment as randomised 
(sometimes referred to as an intention to treat analysis) (score 6) and an adequate 
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investigation and handling of dropouts from assessment if the attrition rate exceeds 15% 
(score 4) 
Active treatment—two questions: maximum score = 11 
Q14: was the treatment adequately described (score 3) and was a treatment protocol or 
manual used (score 3) including adapted  
Q15: was adherence to the treatment protocol or treatment quality assessed (score 5)  
Where the criterion is not reached for any question score = 0 
Total score: maximum score = 100 
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Appendix G: JBI Appraisal Checklist – Prevalence Studies
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Appendix H: JBI Appraisal Checklist – Cross-Sectional Studies 
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